MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11739-026-04318-w

Медицинская библиотека · Internal and emergency medicine · 2026

The impact of body mass index on treatment response to high-dose dexamethasone in adult primary immune thrombocytopenia patients: A two-center retrospective study.

Yıldız Abdulkerim, Çiftçiler Rafiye, Yaman Samet, Aliyeva Minura Abishova, Acar Sedat, Shahab Shabnam, Baysal Huriye

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

High-dose dexamethasone (HDD) is widely used as first-line therapy for immune thrombocytopenia (ITP) and is administered at a fixed dose regardless of body weight. The impact of body mass index (BMI) on treatment response to HDD remains unclear. This retrospective, two-center study included 60 adult patients with newly diagnosed ITP who received HDD as first-line therapy. Demographic characteristics, BMI, baseline laboratory values, and treatment responses at 1, 6, and 12 months were analyzed. BMI was evaluated using cut-off values of 25, 27, and 30. The median number of HDD cycles administered was 1 (range: 1-4), and the median BMI at diagnosis was 27.0 kg/m2 (range: 18.0-44.0). No significant differences were observed between BMI categories with regard to treatment responses at months 1 and 6 (p > 0.05 for both). However, at month 12, a complete response (CR) was more likely in patients with BMI < 30, and a partial response (PR) in those with BMI ≥ 30 (p = 0.023). Across all time points, no other demographic or clinical variable emerged as an independent predictor of treatment response (p > 0.05). The results of this study indicate that in newly diagnosed ITP patients receiving HDD as first-line treatment, BMI does not influence early or durable treatment responses, although it may have a modest adverse effect on late response. Larger prospective studies are needed to clarify underlying mechanisms and assess whether obesity-related factors should inform individualized treatment.

Для цитирования: Yıldız Abdulkerim, Çiftçiler Rafiye, Yaman Samet, Aliyeva Minura Abishova, Acar Sedat, Shahab Shabnam, Baysal Huriye. The impact of body mass index on treatment response to high-dose dexamethasone in adult primary immune thrombocytopenia patients: A two-center retrospective study.. Internal and emergency medicine. 2026. DOI: 10.1007/s11739-026-04318-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.